National Toxicology Program

National Toxicology Program
https://ntp.niehs.nih.gov/go/10278

TDMS Study 99033-03 Pathology Tables

NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: BIORELIANCE                               TRANSGENIC MODEL EVALUATION II (ASPARTAME)                      DATE: 03/05/03       
EXPERIMENT: 99033 TEST: 03                                                                                     TIME: 11:43:24       
TEST TYPE:  SUBCHRON 26-WEEK                    CAGES FROM 0000 TO LAST CAGE                                   PAGE:       1        
CONT: N01-ES-65406                              ROUTE: DOSED FEED                                              NTP C#: 99033B       
PATHOLOGIST: LANNING, LYNDA                                                                                    CAS: 22839-47-0      
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    
                                                        FINAL #3 TG:P16 MICE                                                        
                                                                                                                                    
                                                                                                                                    
               REASONS FOR REMOVAL:    ALL                                                                                          
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
               REMOVAL DATE RANGE:     ALL                                                                                          
                                                                                                                                    
               TREATMENT GROUPS:       INCLUDE ALL                                                                                  
                                                                                                                                   
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: BIORELIANCE                               TRANSGENIC MODEL EVALUATION II (ASPARTAME)                      DATE: 03/05/03       
EXPERIMENT: 99033 TEST: 03                                                                                     TIME: 11:43:24       
TEST TYPE:  SUBCHRON 26-WEEK                    CAGES FROM 0000 TO LAST CAGE                                                        
CONT: N01-ES-65406                              ROUTE: DOSED FEED                                              NTP C#: 99033B       
PATHOLOGIST: LANNING, LYNDA                                                                                    CAS: 22839-47-0      
Mice(P16(INK4A)/(+/-) (C57BL/6))                                                                                                    
-----------------------------                                                                                                       
FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE                                                                   
BASED ON NUMBER OF TISSUES EXAMINED.  IN OTHER TISSUES/ORGANS RATES                                                                 
ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED.                                                                                      
                                                 ---------------                                                                    
                                                 Heart                                                                              
                                                 Lung                                                                               
                                                 Pituitary Gland                                                                    
                                                 Spleen                                                                             
                                                                                                                                   
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: BIORELIANCE                               TRANSGENIC MODEL EVALUATION II (ASPARTAME)                      DATE: 03/05/03       
EXPERIMENT: 99033 TEST: 03                                                                                     TIME: 11:43:24       
TEST TYPE:  SUBCHRON 26-WEEK                    CAGES FROM 0000 TO LAST CAGE                                                        
CONT: N01-ES-65406                              ROUTE: DOSED FEED                                              NTP C#: 99033B       
PATHOLOGIST: LANNING, LYNDA                                                                                    CAS: 22839-47-0      
                                                                                                                                    
                                                                                                                                    
SUMMARY OF STATISTICALLY SIGNIFICANT (P<=.05) RESULTS                                                                               
IN THE ANALYSIS OF       TRANSGENIC MODEL EVALUATION II (ASPA                                                                       
===============================================================                                                                     
Male Mice                                                                                                                           
------------                                                                                                                        
Organ                                 Morphology                                                                                    
-----                                 ----------                                                                                    
All Organs                             Histiocytic Sarcoma                                                                          
                                       Malignant Tumors                                                                             
===============================================================                                                                     
                                                                                                                                   
       Date:  03/05/03                           EXPERIMENT: 99033 TEST: 03                                            Page 1       
Statistical Analysis of Primary Tumors in Mice(P16(INK4A)/(+/-) (C57BL/6))        -        TRANSGENIC MODEL EVALUATION II (ASPA     
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        VEHICLE          3125 PPM         6250 PPM         12500            25000            50000           | 
|                   |        CONTROL                                            PPM              PPM              PPM             | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Hemangiosarcoma                                                                                                             | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        1/15 (7%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)       | 
|POLY-3 RATE (b)    |        0/14.01          1/14.61          0/15.00          0/14.00          0/14.00          0/15.00         | 
|POLY-3 PERCENT (g) |        0.0%             6.9%             0.0%             0.0%             0.0%             0.0%            | 
|TERMINAL (d)       |        0/14 (0%)        1/14 (7%)        0/15 (0%)        0/14 (0%)        0/14 (0%)        0/15 (0%)       | 
|FIRST INCIDENCE    |        ---              274 (T)          ---              ---              ---              ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.482N         P=0.500          (e)              (e)              (e)              (e)             | 
|POLY 3             |        P=0.494N         P=0.508          (e)              (e)              (e)              (e)             | 
|POLY 1.5           |        P=0.492N         P=0.509          (e)              (e)              (e)              (e)             | 
|POLY 6             |        P=0.497N         P=0.505          (e)              (e)              (e)              (e)             | 
|LOGISTIC REGRESSION|        (e)              P=0.500          (e)              (e)              (e)              (e)             | 
|COCH-ARM / FISHERS |        P=0.488N         P=0.500          (e)              (e)              (e)              (e)             | 
|ORDER RESTRICTED   |        P=0.343N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        VEHICLE          3125 PPM         6250 PPM         12500            25000            50000           | 
|                   |        CONTROL                                            PPM              PPM              PPM             | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Hemangiosarcoma                                                                                                             | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        2/15 (13%)       0/15 (0%)        0/15 (0%)        1/15 (7%)       | 
|POLY-3 RATE (b)    |        0/13.51          0/15.00          2/14.49          0/15.00          0/15.00          1/14.92         | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             13.8%            0.0%             0.0%             6.7%            | 
|TERMINAL (d)       |        0/13 (0%)        0/15 (0%)        1/13 (8%)        0/15 (0%)        0/15 (0%)        1/14 (7%)       | 
|FIRST INCIDENCE    |        ---              ---              108              ---              ---              275 (T)         | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.487          (e)              P=0.247          (e)              (e)              P=0.515         | 
|POLY 3             |        P=0.494          (e)              P=0.247          (e)              (e)              P=0.520         | 
|POLY 1.5           |        P=0.493          (e)              P=0.247          (e)              (e)              P=0.517         | 
|POLY 6             |        P=0.494          (e)              P=0.248          (e)              (e)              P=0.522         | 
|LOGISTIC REGRESSION|        P=0.329          (e)              P=0.167          (e)              (e)              P=0.515         | 
|COCH-ARM / FISHERS |        P=0.479          (e)              P=0.241          (e)              (e)              P=0.500         | 
|ORDER RESTRICTED   |        P=0.295          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  03/05/03                           EXPERIMENT: 99033 TEST: 03                                            Page 2       
Statistical Analysis of Primary Tumors in Mice(P16(INK4A)/(+/-) (C57BL/6))       -        TRANSGENIC MODEL EVALUATION II (ASPA      
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        VEHICLE          3125 PPM         6250 PPM         12500            25000            50000           | 
|                   |        CONTROL                                            PPM              PPM              PPM             | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Histiocytic Sarcoma                                                                                                         | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/15 (13%)       1/15 (7%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)       | 
|POLY-3 RATE (b)    |        2/14.01          1/15.00          0/15.00          0/14.00          0/14.00          0/15.00         | 
|POLY-3 PERCENT (g) |        14.3%            6.7%             0.0%             0.0%             0.0%             0.0%            | 
|TERMINAL (d)       |        2/14 (14%)       0/14 (0%)        0/15 (0%)        0/14 (0%)        0/14 (0%)        0/15 (0%)       | 
|FIRST INCIDENCE    |        274 (T)          232              ---              ---              ---              ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.132N         P=0.492N         P=0.221N         P=0.236N         P=0.236N         P=0.221N        | 
|POLY 3             |        P=0.138N         P=0.476N         P=0.216N         P=0.231N         P=0.231N         P=0.216N        | 
|POLY 1.5           |        P=0.138N         P=0.478N         P=0.217N         P=0.232N         P=0.232N         P=0.217N        | 
|POLY 6             |        P=0.138N         P=0.476N         P=0.216N         P=0.231N         P=0.231N         P=0.216N        | 
|LOGISTIC REGRESSION|        P=0.130N         P=0.517N         (e)              (e)              (e)              (e)             | 
|COCH-ARM / FISHERS |        P=0.131N         P=0.500N         P=0.241N         P=0.241N         P=0.241N         P=0.241N        | 
|ORDER RESTRICTED   |        P=0.023N*        (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        VEHICLE          3125 PPM         6250 PPM         12500            25000            50000           | 
|                   |        CONTROL                                            PPM              PPM              PPM             | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Histiocytic Sarcoma                                                                                                         | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        5/15 (33%)       2/15 (13%)       2/15 (13%)       2/15 (13%)       2/15 (13%)       3/15 (20%)      | 
|POLY-3 RATE (b)    |        5/14.00          2/15.00          2/13.55          2/15.00          2/15.00          3/15.00         | 
|POLY-3 PERCENT (g) |        35.7%            13.3%            14.8%            13.3%            13.3%            20.0%           | 
|TERMINAL (d)       |        4/13 (31%)       2/15 (13%)       2/13 (15%)       2/15 (13%)       2/15 (13%)       2/14 (14%)      | 
|FIRST INCIDENCE    |        219              275 (T)          275 (T)          275 (T)          275 (T)          267             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.462N         P=0.155N         P=0.207N         P=0.155N         P=0.155N         P=0.306N        | 
|POLY 3             |        P=0.465N         P=0.166N         P=0.206N         P=0.166N         P=0.166N         P=0.302N        | 
|POLY 1.5           |        P=0.471N         P=0.166N         P=0.194N         P=0.166N         P=0.166N         P=0.302N        | 
|POLY 6             |        P=0.461N         P=0.166N         P=0.216N         P=0.166N         P=0.166N         P=0.302N        | 
|LOGISTIC REGRESSION|        P=0.471N         P=0.179N         P=0.188N         P=0.179N         P=0.179N         P=0.321N        | 
|COCH-ARM / FISHERS |        P=0.487N         P=0.195N         P=0.195N         P=0.195N         P=0.195N         P=0.341N        | 
|ORDER RESTRICTED   |        P=0.128N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  03/05/03                           EXPERIMENT: 99033 TEST: 03                                            Page 3       
Statistical Analysis of Primary Tumors in Mice(P16(INK4A)/(+/-) (C57BL/6))       -        TRANSGENIC MODEL EVALUATION II (ASPA      
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        VEHICLE          3125 PPM         6250 PPM         12500            25000            50000           | 
|                   |        CONTROL                                            PPM              PPM              PPM             | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Malignant Tumors                                                                                                            | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/15 (13%)       2/15 (13%)       0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)       | 
|POLY-3 RATE (b)    |        2/14.01          2/15.00          0/15.00          0/14.00          0/14.00          0/15.00         | 
|POLY-3 PERCENT (g) |        14.3%            13.3%            0.0%             0.0%             0.0%             0.0%            | 
|TERMINAL (d)       |        2/14 (14%)       1/14 (7%)        0/15 (0%)        0/14 (0%)        0/14 (0%)        0/15 (0%)       | 
|FIRST INCIDENCE    |        274 (T)          232              ---              ---              ---              ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.087N         P=0.690N         P=0.221N         P=0.236N         P=0.236N         P=0.221N        | 
|POLY 3             |        P=0.087N         P=0.673N         P=0.216N         P=0.231N         P=0.231N         P=0.216N        | 
|POLY 1.5           |        P=0.087N         P=0.676N         P=0.217N         P=0.232N         P=0.232N         P=0.217N        | 
|POLY 6             |        P=0.087N         P=0.673N         P=0.216N         P=0.231N         P=0.231N         P=0.216N        | 
|LOGISTIC REGRESSION|        P=0.086N         P=0.701          (e)              (e)              (e)              (e)             | 
|COCH-ARM / FISHERS |        P=0.086N         P=0.701N         P=0.241N         P=0.241N         P=0.241N         P=0.241N        | 
|ORDER RESTRICTED   |        P=0.046N*        (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        VEHICLE          3125 PPM         6250 PPM         12500            25000            50000           | 
|                   |        CONTROL                                            PPM              PPM              PPM             | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Malignant Tumors                                                                                                            | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        5/15 (33%)       2/15 (13%)       4/15 (27%)       2/15 (13%)       3/15 (20%)       5/15 (33%)      | 
|POLY-3 RATE (b)    |        5/14.00          2/15.00          4/14.49          2/15.00          3/15.00          5/15.00         | 
|POLY-3 PERCENT (g) |        35.7%            13.3%            27.6%            13.3%            20.0%            33.3%           | 
|TERMINAL (d)       |        4/13 (31%)       2/15 (13%)       3/13 (23%)       2/15 (13%)       3/15 (20%)       4/14 (29%)      | 
|FIRST INCIDENCE    |        219              275 (T)          108              275 (T)          275 (T)          267             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.364          P=0.155N         P=0.500N         P=0.155N         P=0.272N         P=0.585N        | 
|POLY 3             |        P=0.349          P=0.166N         P=0.476N         P=0.166N         P=0.302N         P=0.598N        | 
|POLY 1.5           |        P=0.347          P=0.166N         P=0.467N         P=0.166N         P=0.302N         P=0.598N        | 
|POLY 6             |        P=0.351          P=0.166N         P=0.488N         P=0.166N         P=0.302N         P=0.598N        | 
|LOGISTIC REGRESSION|        P=0.293          P=0.179N         P=0.510N         P=0.179N         P=0.316N         P=0.623N        | 
|COCH-ARM / FISHERS |        P=0.333          P=0.195N         P=0.500N         P=0.195N         P=0.341N         P=0.650N        | 
|ORDER RESTRICTED   |        P=0.340N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  03/05/03                           EXPERIMENT: 99033 TEST: 03                                            Page 4       
Statistical Analysis of Primary Tumors in Mice(P16(INK4A)/(+/-) (C57BL/6))       -        TRANSGENIC MODEL EVALUATION II (ASPA      
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        VEHICLE          3125 PPM         6250 PPM         12500            25000            50000           | 
|                   |        CONTROL                                            PPM              PPM              PPM             | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Malignant and Benign Tumors                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/15 (13%)       2/15 (13%)       0/15 (0%)        1/15 (7%)        0/15 (0%)        1/15 (7%)       | 
|POLY-3 RATE (b)    |        2/14.01          2/15.00          0/15.00          1/14.00          0/14.00          1/15.00         | 
|POLY-3 PERCENT (g) |        14.3%            13.3%            0.0%             7.1%             0.0%             6.7%            | 
|TERMINAL (d)       |        2/14 (14%)       1/14 (7%)        0/15 (0%)        1/14 (7%)        0/14 (0%)        1/15 (7%)       | 
|FIRST INCIDENCE    |        274 (T)          232              ---              274 (T)          ---              274 (T)         | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.340N         P=0.690N         P=0.221N         P=0.500N         P=0.236N         P=0.475N        | 
|POLY 3             |        P=0.361N         P=0.673N         P=0.216N         P=0.500N         P=0.231N         P=0.476N        | 
|POLY 1.5           |        P=0.361N         P=0.676N         P=0.217N         P=0.501N         P=0.232N         P=0.478N        | 
|POLY 6             |        P=0.361N         P=0.673N         P=0.216N         P=0.500N         P=0.231N         P=0.476N        | 
|LOGISTIC REGRESSION|        P=0.349N         P=0.701          (e)              P=0.500N         (e)              P=0.475N        | 
|COCH-ARM / FISHERS |        P=0.350N         P=0.701N         P=0.241N         P=0.500N         P=0.241N         P=0.500N        | 
|ORDER RESTRICTED   |        P=0.222N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        VEHICLE          3125 PPM         6250 PPM         12500            25000            50000           | 
|                   |        CONTROL                                            PPM              PPM              PPM             | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Malignant and Benign Tumors                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        6/15 (40%)       3/15 (20%)       5/15 (33%)       2/15 (13%)       3/15 (20%)       6/15 (40%)      | 
|POLY-3 RATE (b)    |        6/14.00          3/15.00          5/14.49          2/15.00          3/15.00          6/15.00         | 
|POLY-3 PERCENT (g) |        42.9%            20.0%            34.5%            13.3%            20.0%            40.0%           | 
|TERMINAL (d)       |        5/13 (39%)       3/15 (20%)       4/13 (31%)       2/15 (13%)       3/15 (20%)       5/14 (36%)      | 
|FIRST INCIDENCE    |        219              275 (T)          108              275 (T)          275 (T)          267             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.403          P=0.160N         P=0.500N         P=0.081N         P=0.160N         P=0.571N        | 
|POLY 3             |        P=0.385          P=0.178N         P=0.472N         P=0.082N         P=0.178N         P=0.585N        | 
|POLY 1.5           |        P=0.383          P=0.178N         P=0.461N         P=0.083N         P=0.178N         P=0.585N        | 
|POLY 6             |        P=0.388          P=0.178N         P=0.486N         P=0.082N         P=0.178N         P=0.585N        | 
|LOGISTIC REGRESSION|        P=0.338          P=0.187N         P=0.504N         P=0.093N         P=0.187N         P=0.604N        | 
|COCH-ARM / FISHERS |        P=0.369          P=0.213N         P=0.500N         P=0.107N         P=0.213N         P=0.645N        | 
|ORDER RESTRICTED   |        P=0.243N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
(a)  Number of tumor-bearing animals /  number of animals examined at site.                                                         
(b)  Number of tumor-bearing animals / Poly-3 number                                                                                
                                                                                                                                   
(d)  Observed incidence at terminal kill.                                                                                           
(f)  Beneath the control incidence are the P-values associated with the trend                                                       
test.  Beneath the dosed group incidence are the P-values corresponding to                                                          
pairwise comparisons between the controls and that dosed group.  The life                                                           
table analysis regards tumors in animals dying prior to  terminal kill as                                                           
 being (directly or indirectly) the cause of death.                                                                                 
Logistic regression is an alternative                                                                                               
 method for analyzing the incidence of non-fatal tumors. The Cochran-Armitage                                                       
and Fishers exact tests compare directly the overall incidence rates                                                                
For all tests a negative trend is indicated by N                                                                                    
(e)  Value of Statistic cannot be computed.                                                                                         
(g)  Poly-3 adjusted lifetime tumor incidence.                                                                                      
(I)  Interim sacrifice                                                                                                              
(T)  Terminal sacrifice                                                                                                             
#   Tumor rates based on number of animals necropsied.                                                                              
*   To the right of any statistical result, indicates significance at (P<=0.05).                                                    
**  To the right of any statistical result, indicates significance at (P<=0.01).                                                    
NTP is located at the National Institute of Environmental Health Sciences, part of the National Institutes of Health.